Questions a plan sponsor actually asks.
What is Bempedoic Acid and Ezetimibe used for?
Bempedoic Acid and Ezetimibe is a Adenosine Triphosphate-Citrate Lyase Inhibitor medication tracked in Medicare Part D.
Is there a generic for Bempedoic Acid and Ezetimibe?
No. Bempedoic Acid and Ezetimibe is brand-only with no generic equivalents currently in market.
How much does my plan pay for Bempedoic Acid and Ezetimibe?
Across 329 Part D plans, Bempedoic Acid and Ezetimibe averages $13.84/unit (NADAC). Lowest available: $13.84/unit. Highest in distribution: $13.84/unit.
Is Bempedoic Acid and Ezetimibe on the FDA shortage list?
No. Bempedoic Acid and Ezetimibe is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.